◄ back to all posts
Financial data and stock pages provided by
Fintel.io
◄ back to all posts
EBS: Emergent Biosolutions Inc Stock
Written by | Jul 6, 2018
Print FriendlySIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4,122.76 |
| Enterprise Value ($M) | 4,420.76 |
| Book Value ($M) | 1,447.00 |
| Book Value / Share | 27.15 |
| Price / Book | 2.85 |
| NCAV ($M) | -240.30 |
| NCAV / Share | -4.51 |
| Price / NCAV | -17.16 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.13 |
| Return on Assets (ROA) | 0.13 |
| Return on Equity (ROE) | 0.28 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.31 |
| Current Ratio | 3.11 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,195.90 |
| Assets | 2,883.20 |
| Liabilities | 1,436.20 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 433.80 |
| Net Income | 305.10 |
| Earnings Per Share Diluted | 5.67 |
| Earnings Per Share Basic | 5.79 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 536.00 |
| Cash from Investing | -151.00 |
| Cash from Financing | -151.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock Inc. | 10.10 | 0.00 | |
| 13G | Neuberger Berman Group LLC | 6.06 | ||
| 13G/A | Vanguard Group Inc | 9.04 | 2.64 | |
| 13G/A | Dimensional Fund Advisors Lp | 3.32 | -24.79 | |
| 13G/A | Broadfin Capital, LLC | 1.70 | ||
| 13G/A | Bank of New York Mellon Corp | 4.81 | 274.63 | |
| 13G/A | Loomis Sayles & Co L P | 2.20 | ||
| 13G/A | Scopia Capital Management Lp | 0.00 | ||
| 13G/A | Royce & Associates Lp | 0.37 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| Annual Report – 10-K | ||
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 168,311 | 979,948 | 17.18 | |
| 143,946 | 885,488 | 16.26 | |
| 179,110 | 1,310,775 | 13.66 | |
| 179,896 | 1,334,900 | 13.48 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
Financial data and stock pages provided by
Fintel.io
2018/07/06
